Emmanuelle Le Page

Emmanuelle Le Page

UNVERIFIED PROFILE

Are you Emmanuelle Le Page?   Register this Author

Register author
Emmanuelle Le Page

Emmanuelle Le Page

Publications by authors named "Emmanuelle Le Page"

Are you Emmanuelle Le Page?   Register this Author

20Publications

452Reads

49Profile Views

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis.

Mult Scler 2019 May 16:1352458519848090. Epub 2019 May 16.

Department of Neurology, Rennes University Hospital, Rennes, France/West Neuroscience Network of Excellence (WENNE), France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519848090DOI Listing
May 2019

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Mult Scler 2019 04 20;25(4):591-600. Epub 2018 Mar 20.

Service de Neurologie A, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France/Observatoire Français de la Sclérose en Plaques (OFSEP), Lyon, France/Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Equipe Neuro-Oncologie et Neuro-Inflammation, Lyon, France/Université de Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518763080DOI Listing
April 2019

Co-occurrence of MS and ALS: a clue in favor of common pathophysiological findings?

Amyotroph Lateral Scler Frontotemporal Degener 2018 11 3;19(7-8):500-505. Epub 2018 Sep 3.

a Neurology Department , University Hospital Center of Tours , Tours , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678421.2018.1476547DOI Listing
November 2018

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes.

Mult Scler 2017 07 1;23(8):1056-1058. Epub 2017 Feb 1.

Clinical Neuroscience Centre, CIC-P 1414 INSERM, Rennes University Hospital, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517695893DOI Listing
July 2017

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.

J Neurol 2015 21;262(4):1024-34. Epub 2015 Feb 21.

Departement of Neurosciences, University Hospital Pontchaillou, 2 Rue Henri Guilloux, 35000, Rennes Cedex, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-015-7653-3DOI Listing
January 2016

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Brain 2015 Feb 19;138(Pt 2):284-92. Epub 2014 Dec 19.

1 Département de Neurologie, CHU de Montpellier, 34295 Montpellier, France

View Article

Download full-text PDF

Source
http://brain.oxfordjournals.org/content/brain/138/2/284.full
Web Search
http://www.brain.oxfordjournals.org/cgi/doi/10.1093/brain/aw
Publisher Site
http://dx.doi.org/10.1093/brain/awu353DOI Listing
February 2015

Induction therapy for patients with multiple sclerosis: why? When? How?

CNS Drugs 2013 Jun;27(6):403-9

Department of Neurology, CIC-P 02-03 INSERM, INCR, CHU Pontchaillou, 35033, Rennes Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-013-0065-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680663PMC
June 2013

Evidence for a two-stage disability progression in multiple sclerosis.

Brain 2010 Jul 27;133(Pt 7):1900-13. Epub 2010 Apr 27.

Service d'épidémiologie et santé publique, Centre Hospitalier Universitaire, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awq076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892936PMC
July 2010

Long-term experience with induction treatment regimens in multiple sclerosis.

J Neurol Sci 2009 Feb;277 Suppl 1:S46-9

Département de neurologie, Hôopital Pontchaillou, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0022-510X(09)70013-9DOI Listing
February 2009

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

J Neurol Neurosurg Psychiatry 2008 Jan 10;79(1):52-6. Epub 2007 Sep 10.

Service de Neurologie, Hôpital Pontchaillou, rue Henri Le Guilloux, 35 033 Rennes Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp.2007.124958DOI Listing
January 2008

Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assay.

Clin Chim Acta 2007 Feb 30;377(1-2):185-91. Epub 2006 Sep 30.

Laboratoire d'Hormonologie-Marqueurs, CHU Ponchaillou, 35033 Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2006.09.021DOI Listing
February 2007

[Drug therapy in multiple sclerosis].

Rev Prat 2006 Jun;56(12):1336-46

Service de neurologie, hôpital Pontchaillou, 35033 Rennes.

View Article

Download full-text PDF

Source
June 2006

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

J Neurol 2006 Jan 27;253(1):98-108. Epub 2005 Jul 27.

Department of Clinical Neurosciences, Box 165, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-005-0934-5DOI Listing
January 2006

Rationale for the use of mitoxantrone in multiple sclerosis.

J Neurol Sci 2004 Aug;223(1):35-9

Department of Neurology, Rue Henri Le Gallous, CHU Rennes, F 35700 Rennes, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022510X0400117
Publisher Site
http://dx.doi.org/10.1016/j.jns.2004.04.017DOI Listing
August 2004